Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$2.18M Buy
33,614
+14,039
+72% +$819K 0.11% 236
2019
Q2
$1.01M Buy
+19,575
New +$967K 0.05% 355
2018
Q3
Sell
-375,702
Closed -$19.1M 664
2018
Q2
$19.1M Sell
375,702
-454
-0.1% -$21.9K 0.48% 60
2018
Q1
$17.7M Sell
376,156
-4,194
-1% -$213K 0.45% 61
2017
Q4
$18.6M Sell
380,350
-105,390
-22% -$4.7M 0.4% 67
2017
Q3
$22.5M Buy
485,740
+965
+0.2% +$42K 0.51% 51
2017
Q2
$21.9M Sell
484,775
-90
-0% -$3.89K 0.51% 47
2017
Q1
$19.4M Buy
+484,865
New +$18.6M 0.46% 53

Other funds holding MTZ

Boston Advisors's MTZ Position: Q3 2019 in Review

Boston Advisors increased its MasTec (MTZ) stake by 72% in Q3 2019, buying an estimated $819K and bringing the position to 33,614 shares worth $2.18M. The position accounts for 0.11% of the portfolio, ranked #236.

Boston Advisors first reported a position in MTZ in Q1 2017 and has held it in 8 quarters since. The position peaked at $22.5M in Q3 2017. 363 funds tracked by Wall St. Rank hold MTZ as of Q3 2019.

  • Boston Advisors held 33,614 shares of MasTec worth $2.18M as of Q3 2019.
  • Boston Advisors bought 14,039 MasTec shares in Q3 2019, an estimated $819K.
  • MasTec made up 0.11% of Boston Advisors's portfolio in Q3 2019, its #236 holding.
  • Boston Advisors first reported a position in MasTec in Q1 2017 and has held it in 8 quarters since.
  • Boston Advisors's MasTec position peaked at $22.5M in Q3 2017.
  • 363 funds tracked by Wall St. Rank held MasTec as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.